NCT05924789View on ClinicalTrials.gov

Epidemiological Characteristics of Gastric and Pancreatic Cancers in Latin America

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

August 11, 2023

Primary Completion Date

September 24, 2024

Study Completion Date

September 24, 2024

Conditions
Gastric CancerGastroEsophageal CancerPancreatic Cancer
Interventions
OTHER

Observational study

This is an observational study; patients will not be exposed to clinical interventions different from those belonging to the standard of care.

Trial Locations (6)

Unknown

Instituto de Oncología San Gerónimo, Santa Fe

41.950-640

ÉTICA Clínica AMO - Assistência Multidisciplinar em Oncologia, Salvador

90.035-000

HMV - Hospital Moinhos de Vento, Porto Alegre

88.034-000

CEPON - Centro de Pesquisas Oncológicas, Florianópolis

01.323-030

BP - A Beneficência Portuguesa de São Paulo, São Paulo

01.509-001

A.C. Camargo Cancer Center, São Paulo

Sponsors

Collaborators (1)

Astellas Pharma Inc
All Listed Sponsors
collaborator

Astellas Pharma Inc

INDUSTRY

collaborator

Grupo Argentino de Investigación Clínica en Oncología (GAICO)

UNKNOWN

lead

Latin American Cooperative Oncology Group

OTHER

NCT05924789 - Epidemiological Characteristics of Gastric and Pancreatic Cancers in Latin America | Biotech Hunter | Biotech Hunter